Patient Condition
Corporate executives will find work efficiency declining and decision-making difficulties in 2023. At Charité Hospital, a comprehensive assessment showed early AD, MMSE score of 23, positive for amyloid PET, and CDR of 0.5. No family history.
Treatment Timeline
| Phase | Details | Date |
|---|
| Comprehensive assessment of advanced AD | | |
| Aduhelm low-dose treatment + behavioral management | | |
| Maintenance treatment + non-pharmacological intervention | | |
| Long-term maintenance and care support | | |
Treatment Outcome
| before | MMSE score of 23 points, work efficiency is significantly reduced, decision-making is difficult, and concentration is difficult |
|---|
| after | MMSE score of 27 points (improvement of 4 points), stable cognitive function, and able to continue to engage in lightweight management work |
|---|
| highlight | Professional ability is well preserved and retirement time is postponed |
|---|